Blindness News and Research

RSS

Universities and hospitals repurpose existing drugs at significantly lower costs

Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those taking place in the pharmaceutical industry.

16 Jun 2026

Doctors find unexpected regional differences in retinopathy of prematurity in Norway

It's a mystery. The eye disease known as retinopathy of prematurity (ROP) can make infants permanently blind if they are not treated. But there are big differences between how often Norwegian hospitals actually provide this treatment.

16 Jun 2026

AI screening tool increases diabetic eye exam referrals for African Americans

In a study exploring how an AI-assisted diagnostic tool shaped care for underserved populations at multiple community-based primary care sites, investigators at the Wilmer Eye Institute, Johns Hopkins Medicine found that African American patients with diabetes were more likely to receive a diabetic eye exam referral if screened by an AI tool.

9 Jun 2026

Novel artificial intelligence technology improves eye disease diagnosis

Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye's surface without causing discomfort or pain to the patient.

5 Jun 2026

New ultrasound pacemaker design promises minimal recovery time for cardiac patients

MIT engineers have developed a noninvasive pacemaker that stimulates the heart using ultrasound. The design could one day provide a surgery-free alternative to traditional cardiac implants.

2 Jun 2026

PAHO and The Carter Center join hands on the elimination of onchocerciasis across the Americas

The Pan American Health Organization (PAHO) and The Carter Center signed a Technical Cooperation Agreement today to strengthen collaboration on the elimination of onchocerciasis — also known as river blindness — and other communicable diseases in the Americas.

21 May 2026

New eye drop formulation shows promise for dry eye disease

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease.

21 May 2026

Minimal exposure to modern medicine rapidly alters the human microbiome

Even minimal exposure to modern medicine can rapidly change the human microbiome. In a new study publishing May 20 in the Cell Press journal Cell Reports, researchers reveal that the gut microbes of remote Amazonian Indigenous communities began shifting toward patterns more commonly seen in urban, industrialized populations after only a few medical visits.

20 May 2026

How diabetes could drain $5 trillion from the global economy by 2050

A macroeconomic modelling study across 190 countries and territories estimates that diabetes could reduce global economic output by INT$5.177 trillion between 2021 and 2050. Most projected losses stem from diabetes-related disability and morbidity, with high-income countries facing the largest dollar losses and low- and middle-income countries carrying most of the disease burden.

12 May 2026

Study identifies genetic cause linked to juvenile glaucoma risk

A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma.

7 May 2026

CGRP inhibitors may reduce glaucoma risk among migraine patients

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

6 May 2026

Study reveals epigenetic adaptation of beta cells across lifespan and disease

As people age, most maintain normal blood sugar even as insulin resistance tends to rise. New research suggests that pancreatic beta cells help meet this demand through gradual epigenetic changes in regulatory regions of the genome that support beta-cell identity and function.

5 May 2026

WHO validates Australia for eliminating trachoma as public health problem

The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of Indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs).

29 Apr 2026

Algeria eliminates trachoma as a public health problem after decades of effort

The World Health Organization (WHO) has validated Algeria as having eliminated trachoma as a public health problem, making it the 10th country in WHO's African Region and the 29th country globally to achieve this significant milestone.

24 Apr 2026

Real-time CGM transforms blood glucose management in type 2 diabetes

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults living with type 2 diabetes who are treated with basal insulin.

23 Apr 2026

Benefits from food fortification, yet global nutrient gaps persist

While food fortification reduces micronutrient inadequacies, additional interventions are necessary to ensure balanced nutrition and prevent excess intake.

30 Mar 2026

Dual sensory loss affects confidence in navigation and sound localization

According to a recent multi-institute PLOS One study led by the Multisensory Research Lab at the Wilmer Eye Institute, Johns Hopkins Medicine, time of hearing loss onset is a key determinant of patient confidence and self-reported sound localization abilities - the ability to perceive and locate objects in an environment - even in individuals who use hearing aids or who have received vision rehabilitation training.

11 Mar 2026

New CRISPR technique boosts mitochondrial function to treat heart failure

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a result ⎯ a condition that impacts 6.8 million Americans and carries a high lifetime risk with 1 in 4 adults in the U.S. expected to develop the condition during their lifetime.

9 Mar 2026

COVID-19 lockdown timing tied to changes in executive function

The COVID-19 pandemic affected executive function in young children, with preschoolers showing different cognitive growth patterns linked to maternal education.

6 Mar 2026